ANSWER: Heart failure is simply when the heart is unable to pump all the blood it needs to meet the body’s demands. Heart ...

For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes or worsening heart failure.

The EF is normally 50% to 75%, so heart failure with an EF of less than 50% is heart failure with reduced ejection fraction ...

NYHA class was more likely to have improved at 1 year in the treatment ... EF = ejection fraction; HF = heart failure; HR = hazard ratio; I-PRESERVE = irbesartan in heart failure with preserved ...

SGLT2 inhibitors plus finerenone may have a protective effect against cardiovascular events in patients with HFpEF or HFmrEF.

Understanding how patients with heart failure with preserved ejection fraction (HFPEF ... thereby allowing better prediction of response to therapy in designing clinical trials.

A recent study published in the Frontiers in Endocrinology journal showed that heart failure with preserved ejection fraction (HFpEF ... Even with advancements in treatment, heart failure (HF) ...

Heart failure and arrhythmias together pose a critical healthcare issue with high risks of morbidity and mortality globally. Emerging evidence underscores ...

To achieve this goal, we established ... for NHS use as a treatment for symptomatic chronic heart failure (CHF) with preserved or mildly reduced ejection fraction in new draft guidance.

A recent groundbreaking study found that in patients having Heart failure with mildly reduced ejection fraction (HFmrEF ... captivating and informative medical content for a wider audience. She can be ...